Month: February 2021

Bonjour,Veuillez trouver ci-dessous le lien pour consulter le commuiqué de presse annonçant les résultats annuels 2020 de Publicis Groupe :Communiqué de presse Please find below the link to the press release announcing Publicis Groupe Full Year 2020 Results :Press release   

Bonjour,Veuillez trouver ci-dessous le lien pour consulter le commuiqué de presse annonçant les résultats annuels 2020 de Publicis Groupe :Communiqué de presse Please find below the link to the press release announcing the Publicis Groupe Full Year 2020 Results :Press release   

SAN DIEGO, Feb. 02, 2021 (GLOBE NEWSWIRE) — Mitek Systems, Inc. (“Mitek”) announced today the pricing of its private offering of $135,000,000 aggregate principal amount of 0.750% Convertible Senior Notes due 2026 (the “Notes”) in a private offering. The Notes will be offered and sold only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering size was increased from the previously announced offering size of $125,000,000 aggregate principal amount of notes. Mitek has granted the initial purchasers of the Notes an option to purchase up to an additional $20,250,000 aggregate principal amount of Notes. The offering is expected to close on February 5, 2021, subject to customary closing conditions.The Notes will be Mitek’s...

VANCOUVER, British Columbia, Feb. 03, 2021 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company, focused on cannabis, hemp, functional mushrooms, and the rapidly emerging psychedelic sector, is pleased to announce that it recently completed its new company registration with the Natural and Non-prescription Health Products Directorate (NNHPD) and received its Company Code. This has allowed Pure Extracts to submit a Class 1 Natural Product Number (NPN) application for a functional mushroom product, which the Company expects will be the first of several NPN applications that it submits in 2021.Pure Extracts plans to sell functional mushroom wellness products through its newly incorporated, wholly owned subsidiary, Pure Mushrooms...

VANCOUVER, British Columbia, Feb. 03, 2021 (GLOBE NEWSWIRE) — Metallica Metals Corp. (CSE: MM) (OTC: MTALF) (FWB: SY7P) (the “Company” or “Metallica Metals”) is pleased to discuss its Starr gold-silver project (“Starr” or the “Project”) and exploration plans for this Project during the 2021 field season. The Project, which the Company has the right to earn up to a 100% interest, covers a large land position of 5,991 hectares that includes several high-grade gold and silver occurrences within a 20 km long segment of the southwestern section of the Shebandowan Greenstone Belt in the Thunder Bay Mining District of Ontario. The Project is accessible year-round by highway and logging roads and is located in close proximity to the Moss Lake gold deposit owned by Wesdome Gold Mines Ltd. and the Huronian Gold Property owned by Kesselrun...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Feb. 02, 2021 (GLOBE NEWSWIRE) — Global Care Capital Inc. (CSE:HLTH, FRANKFURT: L6V1) (the “Company” or “Global Care”) a global investment company which engages in early stage investment opportunities in private and public companies is pleased to announce that its 100% owned portfolio company, HealthView Technologies Inc. (“HealthView”) has onboarded its first customers across the retail, hospitality, medical, finance and transportation industries to offer Mental Health Services and has achieved its first of two earn-out milestones in accordance with the terms of the definitive agreement that was entered in connection with the acquisition of HealthView by the Company (the “Transaction”).On January 25th, 2021,...

Regulated information — Inside informationFebruary 2, 2021, 10:15 PM ESTFebruary 3, 2021, 4:15 AM CETBreda, the Netherlands — argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, announced today the pricing of a global offering of ordinary shares represented by American Depository Shares (ADSs) in the United States and certain other countries outside of European Economic Area and a simultaneous private placement of ordinary shares in the European Economic Area and the United Kingdom. The Company anticipates total gross proceeds of approximately $1.0 billion (approximately €830.3 million) from the sale of 1,608,000 ADSs at a price of $320.00 per ADS and the sale of 1,517,000 ordinary shares at a price of €265.69 per ordinary...

VANCOUVER, British Columbia, Feb. 02, 2021 (GLOBE NEWSWIRE) — Affinor Growers Inc. (“Affinor” or the “Company”) (CSE: AFI) (OTCQB: RSSFF) is pleased to announce that Nick Brusatore has been appointed as a non-independent member of the Company’s Audit Committee. Mr. Brusatore will also continue in his roles as Chief Executive Officer and as director of the Company.Nick Brusatore: This is a great first step in building trust with our current shareholder base, we hope to increase our exposure in the market with the completion of the new Abbotsford greenhouse operation.About AffinorAffinor is a publicly traded company listed on the CSE under the symbol “AFI” and on the OTCQB under the symbol “RSSFF”. Affinor is focused on developing vertical farming technologies and using those technologies to grow fruits and vegetables...

SAN FRANCISCO, Feb. 02, 2021 (GLOBE NEWSWIRE) — Kernel Group Holdings, Inc. (the “Company”) today announced the pricing of its upsized initial public offering of 26,500,000 units at $10.00 per unit. The units will be listed on the Nasdaq Capital Market (“Nasdaq”) and trade under the ticker symbol “KRNLU” beginning on February 3, 2021. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “KRNL” and “KRNLW,” respectively. The initial public offering is expected to close on February 5, 2021, subject to customary closing...

PITTSBURGH, Feb. 02, 2021 (GLOBE NEWSWIRE) — Krystal Biotech Inc. (NASDAQ: KRYS) (the “Company), the leader in redosable gene therapies for rare diseases, today announced that it has priced the previously announced underwritten public offering of 1,923,077 shares of its common stock, at a public offering price of $65.00 per share. The Company granted the underwriters a 30-day option to purchase up to an additional 288,461 shares of its common stock. The gross proceeds to the Company from this offering are expected to be approximately $125 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company. The offering is expected to close on or about February 5, 2021, subject to satisfaction of customary closing conditions.Goldman Sachs & Co. LLC, Cowen, and Evercore...